Portal:ExRNA/FeaturedPathways
From WikiPathways
(Difference between revisions)
Line 1: | Line 1: | ||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
{| style="margin: 10px; background-color:#efefef" | {| style="margin: 10px; background-color:#efefef" | ||
|width=100px; cell padding=50px|{{#pwImage:Pathway:WP2583|250px||T-Cell Receptor and Co-stimulatory Signaling}} | |width=100px; cell padding=50px|{{#pwImage:Pathway:WP2583|250px||T-Cell Receptor and Co-stimulatory Signaling}} | ||
Line 27: | Line 15: | ||
|width=100px|{{#pwImage:Pathway:WP2811|250px||mir219 in Oligodendrocyte Differentiation and Myelination}} | |width=100px|{{#pwImage:Pathway:WP2811|250px||mir219 in Oligodendrocyte Differentiation and Myelination}} | ||
[http://dx.doi.org/10.1002/glia.22606 Pusic, et al. Youth and environmental enrichment generate serum exosomes containing miR-219 that promote CNS myelination] | [http://dx.doi.org/10.1002/glia.22606 Pusic, et al. Youth and environmental enrichment generate serum exosomes containing miR-219 that promote CNS myelination] | ||
- | |||
|width=100px|{{#pwImage:Pathway:WP2864|250px||Apoptosis-related network due to altered Notch3 in ovarian cancer}} | |width=100px|{{#pwImage:Pathway:WP2864|250px||Apoptosis-related network due to altered Notch3 in ovarian cancer}} | ||
[http://dx.doi.org/10.1158/0008-5472.CAN-13-2066 Hu, et al. Notch3 pathway alterations in ovarian cancer] | [http://dx.doi.org/10.1158/0008-5472.CAN-13-2066 Hu, et al. Notch3 pathway alterations in ovarian cancer] | ||
|- | |- | ||
- | |width=100px|{{#pwImage:Pathway: | + | |width=100px|{{#pwImage:Pathway:WP1544|250px||MicroRNAs in cardiomyocyte hypertrophy}} |
- | + | |width=100px|{{#pwImage:Pathway:WP2011|250px||REBF and miR33 in cholesterol and lipid homeostasis}} | |
+ | |width=100px|{{#pwImage:Pathway:WP1991|250px||SRF and miRs in Smooth Muscle Differentiation and Proliferation}} | ||
+ | |width=100px|{{#pwImage:Pathway:WP1530|250px||miRNA Regulation of DNA Damage Response}} | ||
+ | |- | ||
+ | |width=100px|{{#pwImage:Pathway:WP2001|250px||miR-targeted genes in adipocytes - TarBase}} | ||
+ | |width=100px|{{#pwImage:Pathway:WP2002|250px||miR-targeted genes in epithelium - TarBase}} | ||
+ | |width=100px|{{#pwImage:Pathway:WP2003|250px||miR-targeted genes in leukocytes - TarBase}} | ||
+ | |width=100px|{{#pwImage:Pathway:WP2004|250px||miR-targeted genes in lymphocytes - TarBase}} | ||
+ | |- | ||
+ | |width=100px|{{#pwImage:Pathway:WP2005|250px||miR-targeted genes in muscle cell - TarBase}} | ||
+ | |width=100px|{{#pwImage:Pathway:WP2006|250px||miR-targeted genes in squamous cell - TarBase}} | ||
+ | |width=100px|{{#pwImage:Pathway:WP1992|250px||TarBasePathway}} | ||
|} | |} |
Revision as of 19:50, 4 November 2014
Image does not exist |
Image does not exist |
Image does not exist Ozpolat, et al. Liposomal siRNA nanocarriers for cancer therapy |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |